rs77416795

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000636183.2(CLN5):​c.-144C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.122 in 1,563,562 control chromosomes in the GnomAD database, including 12,378 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1362 hom., cov: 33)
Exomes 𝑓: 0.12 ( 11016 hom. )

Consequence

CLN5
ENST00000636183.2 5_prime_UTR

Scores

1
2
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 0.316

Publications

17 publications found
Variant links:
Genes affected
CLN5 (HGNC:2076): (CLN5 intracellular trafficking protein) This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.[provided by RefSeq, Oct 2008]
CLN5 Gene-Disease associations (from GenCC):
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 5
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women's Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000636183.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004951477).
BP6
Variant 13-76991955-C-T is Benign according to our data. Variant chr13-76991955-C-T is described in ClinVar as Benign. ClinVar VariationId is 128782.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.201 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000636183.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN5
NM_006493.4
MANE Select
c.-144C>T
upstream_gene
N/ANP_006484.2O75503
CLN5
NM_001366624.2
c.-144C>T
upstream_gene
N/ANP_001353553.1A0A1B0GTR6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN5
ENST00000636183.2
TSL:1
c.-144C>T
5_prime_UTR
Exon 1 of 4ENSP00000490181.2O75503
CLN5
ENST00000377453.9
TSL:1 MANE Select
c.-144C>T
upstream_gene
N/AENSP00000366673.5O75503
ENSG00000283208
ENST00000638147.2
TSL:5
c.-144C>T
upstream_gene
N/AENSP00000490953.2A0A1B0GWJ7

Frequencies

GnomAD3 genomes
AF:
0.128
AC:
19446
AN:
152048
Hom.:
1361
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.137
Gnomad AMI
AF:
0.0418
Gnomad AMR
AF:
0.207
Gnomad ASJ
AF:
0.0887
Gnomad EAS
AF:
0.122
Gnomad SAS
AF:
0.126
Gnomad FIN
AF:
0.109
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.112
Gnomad OTH
AF:
0.116
GnomAD2 exomes
AF:
0.145
AC:
23394
AN:
160952
AF XY:
0.139
show subpopulations
Gnomad AFR exome
AF:
0.150
Gnomad AMR exome
AF:
0.280
Gnomad ASJ exome
AF:
0.0942
Gnomad EAS exome
AF:
0.113
Gnomad FIN exome
AF:
0.103
Gnomad NFE exome
AF:
0.113
Gnomad OTH exome
AF:
0.139
GnomAD4 exome
AF:
0.121
AC:
171247
AN:
1411396
Hom.:
11016
Cov.:
35
AF XY:
0.121
AC XY:
84441
AN XY:
699018
show subpopulations
African (AFR)
AF:
0.142
AC:
4618
AN:
32530
American (AMR)
AF:
0.272
AC:
10487
AN:
38574
Ashkenazi Jewish (ASJ)
AF:
0.0913
AC:
2315
AN:
25360
East Asian (EAS)
AF:
0.111
AC:
4144
AN:
37184
South Asian (SAS)
AF:
0.130
AC:
10586
AN:
81484
European-Finnish (FIN)
AF:
0.102
AC:
4148
AN:
40574
Middle Eastern (MID)
AF:
0.112
AC:
629
AN:
5594
European-Non Finnish (NFE)
AF:
0.117
AC:
127258
AN:
1091356
Other (OTH)
AF:
0.120
AC:
7062
AN:
58740
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
8562
17125
25687
34250
42812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4832
9664
14496
19328
24160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.128
AC:
19457
AN:
152166
Hom.:
1362
Cov.:
33
AF XY:
0.128
AC XY:
9498
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.137
AC:
5672
AN:
41512
American (AMR)
AF:
0.207
AC:
3175
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0887
AC:
308
AN:
3472
East Asian (EAS)
AF:
0.121
AC:
628
AN:
5172
South Asian (SAS)
AF:
0.126
AC:
607
AN:
4824
European-Finnish (FIN)
AF:
0.109
AC:
1151
AN:
10598
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.112
AC:
7608
AN:
67970
Other (OTH)
AF:
0.114
AC:
240
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
884
1768
2653
3537
4421
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.114
Hom.:
1725
Bravo
AF:
0.136
Asia WGS
AF:
0.111
AC:
386
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
3
not provided (3)
-
-
2
Neuronal ceroid lipofuscinosis (2)
-
-
2
Neuronal ceroid lipofuscinosis 5 (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
13
DANN
Uncertain
0.98
DEOGEN2
Benign
0.067
T
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.69
FATHMM_MKL
Benign
0.075
N
LIST_S2
Benign
0.41
T
MetaRNN
Benign
0.0050
T
MetaSVM
Benign
-1.0
T
PhyloP100
0.32
PrimateAI
Uncertain
0.58
T
PromoterAI
0.080
Neutral
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs77416795;
hg19: chr13-77566090;
COSMIC: COSV66283779;
COSMIC: COSV66283779;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.